ALXN2080

DRUG3 trials

Sponsors

Alexion Pharmaceuticals, Inc.

Conditions

Healthy

Phase 1

Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants

CompletedNCT05428696

Alexion Pharmaceuticals, Inc.Healthy

Start: 2022-09-12End: 2023-05-26Updated: 2024-06-07

A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants

CompletedNCT06160414

Alexion Pharmaceuticals, Inc.Healthy

Start: 2023-04-12End: 2024-02-05Updated: 2025-04-24

A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults

CompletedNCT06173596

Alexion Pharmaceuticals, Inc.Healthy

Start: 2024-01-10End: 2024-05-16Updated: 2024-06-20